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SUMO (Small Ubiquitin-like Modifier) is a small protein that becomes reversibly 
attached to a large number of proteins. While research has firmly established SUMO’s 
importance in modulating protein interactions, activation, targeting, and half-life, little is known 
about its role in the SUMO-Stress Response (SSR), a phenomenon that involves a rapid increase 
in SUMOylation in response to cellular stress. Here I describe the use of kmUTAG-fl, a novel 
fluorescent SUMO trapping UTAG protein, to characterize and study how the SSR unfolds in 
normal and carcinogenic tissue culture cells. Specifically, fixed cells were stained with the 
SUMO-conjugate specific kmUTAG-fl reagent to record and quantitate differences between 
normal (PNT2) and carcinogenic cells (PC3). While both types of cells displayed grossly altered 
SUMO level, carcinogenic cells featured a more rapid and reproducible increase of 
SUMOylation in both the nucleus and the cytosol. This elevated SSR, potentially unique to 






A Large Fraction of the Proteome is Sumoylated 
SUMOylation is a post-translational modification that modifies thousands of eukaryotic 
proteins via conjugation with the 12 kDa SUMO (Small Ubiquitin-like Modifiers) protein 
[Kerscher 2006 & 2016]. This proteinaceous modification is conserved in a variety of organisms, 
from yeast to humans. SUMO proteins themselves are synthesized as precursor proteins, which 
are processed and rendered conjugation competent by specific SUMO proteases (i.e. the 
SUMO1/sentrin specific peptidase (SENP) in mammalian cells or the Ubl-specific protease 
(ULP1) in yeast). This processing exposes the c-terminal di-glycine (GG) motif of SUMO. 
SUMO then becomes activated by a heterodimeric E1 activating enzyme, which yields a SUMO-
E1 thioester in an ATP-dependent reaction. Next, SUMO is transferred from the E1 thioester to 
the lysine residue of E2 conjugating enzyme Ubc9, again forming a thioester. In vivo, the final 
transfer of SUMO to the lysine of a substrate (or target) protein is facilitated by several SUMO 
E3 ligases. SUMO can also form poly-SUMO chains when additional SUMO monomers are 
conjugated to internal lysine residues of conjugated SUMO monomers [Kerscher 2006]. In 
contrast, SUMOylation can be rapidly reversed by the activity of SUMO proteases including 
Ulp1 or Ulp2 in yeasts, and SENP1-7 in mammalian cells [Hickey, Wilson, & Hochstrasser 
2012]. In fact, only a small fraction of SUMO substrates are sumoylated at steady state, while 
most of the substrates are transiently modified with SUMO proteins.  
SUMO modification is also involved in the functional crosstalk with ubiquitin, a 
ubiquitious regulatory protein that tags proteins for proteasomal degradation. SUMO chains that 
have formed on their respective target proteins can become ubiquitylated via the activity of 
SUMO-targeted ubiquitin ligases (STUbLs) [Xie et al 2007]. This dual modification with SUMO 
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and ubiquitin serves as a signal for protein complex disassembly and degradation [reviewed in 
Kerscher 2016]. 
A large fraction of the proteome is sumoylated. It was recently reported that between 
1,000 to 3,000 proteins (or ~18% of the human proteome) can become sumoylated [Golebiowski 
et al., 2009]. Using a mass spectrometry aproach, one group of researchers identified 1,600 
proteins as SUMO targets in HeLa cells and grouped them according to their Gene Ontology 
Cellular Compartments [Hendriks et al., 2014]. 50% of the proteins were found exclusively in 
the nuclear compartment (chromosome and nucleus), 25% of the proteins were found to reside in 
both the nucleus and cytosol, and the rest of the 25% were found in cytoplasm and cellular 
membranes. Thus they confirmed the prediction that SUMOylation is predominantly a nuclear 
process, for over half of the SUMO targets were nuclear proteins. 
Researchers have yet to elucidate the SUMO-dependent functions of many of these 
sumoylated proteins. However, SUMO-modification seems to be associated with the majority of 
cellular processes, including gene expression, genome stability, DNA replication, cell-cycle 
progression, transcription, translation, and repair. SUMO frequently affects protein targeting, 
signaling localization and half-life of its substrate, thus playing pivotal roles in the cellular 
processes these proteins are involved in [Wilson 2009].  
For example, SUMO acts as an activator and repressor of gene expression via modulating 
DNA methylation through DNMT1 activation or demethylation through E3 ligase RNF4, 
deacetylation via SUMOylation of HDACs [Cubeñas-Potts & Matunis, 2013]. SUMO can also 
maintain the proper nuclear architecture via targeting RanGAP1 to the nuclear pore complex 
protein RanBP2 [Nacerddine et al., 2005; Mahajan et al., 1998]. SUMO also regulates cell-cycle 
progression via modifying important cell cycle regulators like CDK1 [Xiao et al., 2016], mdm2 
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[Buschmann et al., 2001] and anaphase-promoting complex/cyclosome (APC/C) [Eifler et al., 
2018]. 
 
Cells Utilize the SUMO-Stress Response (SSR) to Cope with Stress 
Cells are frequently exposed to environmental and intrinsic stress. Environmental stresses 
include temperature, radiation, oxidizing reagents, as well as shear and osmotic stress. These 
stresses may induce intrinsic stress, which can also stem from ROS (reactive oxygen species) 
produced due to normal or abnormal metabolic processes, telomere shortening, DNA damage, 
and the expression of oncogenes. These stressors are harmful to cells and may lead to reduced 
cellular fitness and even cell death. 
The SUMO-Stress Response (SSR) refers to the phenomenon in which the SUMO 
conjugation level is dramatically elevated when cells are confronted with stress [Lewicki et al., 
2015]. For example, SUMO-modification is rapidly enhanced when cells are treated with high 
levels of hydrogen peroxide, an oxidizing reagent, as well as heat shock stress [Saitoh & Hinchie, 
2000]. Over the past decades, researchers have identified a number of proteins that become 
preferentially sumoylated with the onset of stress, and some of them are described below 
[Golebiowski et al., 2009]. Indeed, evidence is mounting that SUMO modification is used by a 
diverse array of organisms, ranging from yeast to humans, to cope with exposure to proteotoxic 
and genotoxic stress. 
First, SUMO modification is important for cells coping with genotoxic stress, for SUMO 
is involved in almost all levels of DNA damage repair mechanisms, including base excision 
repair (BER), non-homologous end-joining (NHEJ), translesion synthesis (TLS) and 
homologous recombination (HR) [Seeler and Dejan, 2017]. The initial link between SUMO 
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modification and DNA damage response was established through studies on BER (REF). During 
BER, DNA glycosylases recognize and enzymatically removes the lesions, yielding abasic sites 
which is further processed and repaired. However, the binding of abasic sites to certain 
glycosylase is strong thus impairing the turnover. To increase the turnover, SUMO1 molecules 
become covalently attached to the C-terminus lysine of glycosylase and trigger the 
conformational change in the N-terminus and hence modulates the DNA binding activity of 
glycosylase to abasic sites [Steinacher and Schär, 2005]. Meanwhile, SUMOylation is significant 
for the faithful transmission of genetic information because it modulates centromere and 
telomere function, mitosis and meiosis [reviewed in Seeler and Dejan, 2017]. This is also borne 
out by SUMO’s modification of chromatin structure and function and hence the influence on 
gene expression and genome integrity [Cubeñas-Potts & Matunis, 2013]. 
SUMO is, at the same time, important for the ability to withstand proteotoxic stress. 
Upon exposure to proteotoxic stress, SUMO conjugation is boosted, indirectly modulating the 
transcription of heat shock proteins and, due to a proposed chaperone-like function, maintaining 
protein complex homeostasis [Seifert et al., 2015]. Using chromatin immunoprecipitation assays 
concomitant with high-throughput DNA sequencing and mRNA sequencing, researchers found 
that in response to proteotoxic stress, SUMO2 accumulates at regions of actively transcribed 
chromatin. Here SUMO modulates gene expression through modulating protein complex 
stability, stabilizing the gene promoter and DNA regulatory protein complexes. As such SUMO 
exerts a “scaffolding effect” where SUMO can promote the interaction between SUMO and 
proteins that contain SUMO-interacting motifs. After stress abates, the scaffolding effect can be 
reversed via the de-SUMOylation by SUMO protease. Another study suggests that SUMO 
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modification enhances protein solubility upon heat shock, stabilizing denatured proteins from 
aggregation before proteome degradation [Liebelt et al., 2018]. 
 
SSR and the Stress Resilience of Cancer Cells 
Cancerous cells are under the constant threat of adverse conditions, including hypoxia 
within tumors [Muz et al., 2015], immune invasions, and aneuploidies that threatens protein 
homeostasis [Oromendia & Amon, 2014]. Thus, cancer cells require enhanced stress response 
pathways to mitigate the effect of cellular damage caused by proteotoxic and genotoxic stress 
and to maintain proteostasis and genome integrity, as detailed above. 
Both SUMO and the SSR also play a role in cancer progression. Recent work shows that 
several enzymes in the SUMO pathway are upregulated in cancer [Seeler and Dejan, 2017]. For 
example, SUMO proteases (SENPs) levels are elevated in bladder, breast, gastric, multiple 
myeloma, neuroblastoma, pancreatic, prostate, thyroid, colon, rectum, ovary and lung cancers 
[reviewed in Seeler and Dejan, 2017]. Specifically, in prostate cancer cells SENP1 and SENP3 
(SUMO2/3 de-conjugating enzyme) level are elevated [Bawa-Khalfe & Yeh, 2010]. SENP1 is 
involved in the pathogenicity of prostate cancer via altering the transcription of androgen-
receptor via the histone de-acetylase HDAC1 [Bawa-Khalfe et al., 2007]. This upregulates c-Jun 
dependent transcription and increases cell cycle progression via expression of the cell cycle 
regulator Cyclin D1. SENP3, another SENP found in nucleoplasm with low levels detected in 
cytoplasm, also enhances the tumorigenicity of prostate cancer [Bawa-Khalfe & Yeh, 2010]. 
SENP3 can initiate angiogenic pathway by regulating the transcription of hypoxia-inducible 
factor 1α (HIF-1α) via deSUMOylating a transcription coregulatory protein.  
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In contrast, breast cancer exhibits a different SUMO protease profile. Breast cancer is 
associated with reduced SENP6 mRNA level, and enhanced Ubc9 (E2) and PIAS3 (an E3) levels. 
The reduced SENP6 level corresponds to the increased SUMOylation level. It follows that 
dysregulation of SUMO levels, rather than an increase or decrease, is associated with the 
potential of a cell to become cancerous. 
Meanwhile, the SUMO E1, E2, E3 levels are also altered in cancer cells. Specifically, the 
SUMO E2 ligase Ubc9 is upregulated in breast, lung, neck and head cancer specimens, and is 
elevated 5.7-fold in breast tumors compare to normal breast tissues [Wu et al., 2009]. Ubc9 may 
also present a useful biomarker for cervical cancer and is linked to the progression of HPV’s 
oncogenicity [Mattoscio, 2015]. In summary, an enhanced SSR is correlated to the stress-
resilience of cancer cells 
 
A Novel Fluorescent SUMO-Trapping UTAG Reagent can Detect Increases in SUMO 
While the importance of SUMO modification is well appreciated, the specific function of 
SUMO modification in many pathways remains enigmatic at best. This underscores the need for 
a robust, reliable and readily available tool for the detection and purification of SUMOylated 
proteins in a variety of model systems. Anti-SUMO antibodies and expression of epitope-tagged 
SUMOs are mostly utilized for the detection and isolation of SUMO modified proteins. However, 
some commercially available SUMO-specific antibodies are expensive, limited in availability, 
have variable affinities and cross-reactivity. In some cases, the results lack reproducibility [Baker, 
2015]. Similarly, the expression of expression of epitope-tagged SUMO to transform cell also 
has drawbacks, as the tags may interfere with substrate binding (Z. Wang & Prelich, 2009). 
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Meanwhile, epitope tags are not applicable to untransformed cells, thus limiting the scope of 
their application. 
Previously, we developed a novel SUMO-trapping protein from a thermotolerant yeast, 
Kluyveromyces marxianus (“Km” for short) [Peek et al., 2018]. Specifically, we generated a 
catalytically inactive recombinant SUMO-trapping fragment of the UD domain of the Ulp1 (the 
yeast SUMO protease) [Peek et al., 2018], termed kmUTAG. In this study we performed a 
detailed examination of the SUMO-trapping features of the kmUTAG. For example, we showed 
that KmUTAG can efficiently bind a variety of purified SUMO isoforms and bind immobilized 
SUMO1 with nanomolar affinity (~12.8nM). Moreover, KmUTAG has high affinity for SUMO 
and SUMO-modified proteins even in the presence of oxidative stressors (0.6% H2O2, Picture ), 
reducing agents (5mM TCEP Tris(2-carboxyethyl)phosphine hydrochloride), denaturants (up to 
2M UREA) and temperature (42°C) stress that induce protein misfolding. 
 
Picture 5. kmUTAG is a stress resilient SUMO trapping reagent. Recombinant KmUTAG or ScUTAGs (a non-
stress resilient UTAG developed from Saccharomyces cerevisiae) were pulled down with SUMO1 beads with a 
reducing agent TCEP [5mM] or with 0.006%, 0.06% and 06% hydrogen peroxide (H2O2). kmUTAG binding to 
SUMO1 beads can resist up to 0.6% H2O2 stress (lane 8). For details see Peek et al., 2018. 
  
  To visualize SUMO with the kmUTAG, we developed a fluorescent SUMO trapping 
UTAG reagent termed kmUTAG-fl (Yin et al., 2019). kmUTAG-fl is a recombinant, mCherry-
tagged SUMO-trapping fusion protein. This stress-tolerant pan-SUMO specific reagent is 
produced recombinantly in bacteria. Once purified it recognizes and traps native SUMO-
conjugated proteins and SUMO chains in fixed permeablized cells. Compared to commercially 
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available SUMO antibodies, this reagent has reduced affinity for free, unconjugated SUMO. 
Meanwhile, it can be used to analyze SUMO variants from additional model and non-model 
systems. In our recently published work, we show that kmUTAG-fl can detect SUMO 
orthologues in c. elegans worms, which substantiated pan-SUMO binding ability of kmUTAG-fl. 







The specific aims of this thesis are as follows: 
1. Demonstrate the SUMO-trapping activity of kmUTAG-fl in mammalian tissue culture 
systems for the analysis of SUMO modification. I will compare and evaluate the SUMO-stain 
pattern of fluorescent pan-SUMO specific SUMO trapping reagent kmUTAG-fl to that of the 
antibody, and demonstrate that kmUTAG-fl tags SUMO-modified proteins in tissue culture cells. 
2. Visualize and characterize the SSR in mammalian cells under stress conditions. Using the 
fluorescent SUMO-trap, I will visualize SUMO conjugates in fixed tissue culture cells that are 
treated with UV-irradiation or H2O2. I will characterize the change in SUMO level which is 
indicative of SUMO stress response. 
3. Compare and contrast the SSR in cancer versus normal cells. I predict that a measurable 
increase in SSR and stress-related SUMOylation will be observed in carcinogenic prostate cancer 








MATERIALS AND METHODS 
Cell Culture and Maintenance 
Frozen tissue culture cells PC3 and PNT2 were thawed and warmed at 37°C for a few 
minutes before transferred to a 15 ml conical tube with 5ml RPMI media containing 10% heat 
inactivated FBS (ThermoFisher Scientific #10438018) and 1% antifungal/antibiotic (anti/anti) 
(ThermoFisher Scientific #15240062). Cells were gently centrifuged for 2 minutes at 1000 rpm 
and the media was removed, while keeping the cell pellet intact. After resuspended in 1 ml media, 
the cells were added to a TC-treated tissue culture flask (surface area 25 cm2, angled neck, cap 
(phenolic-style)) containing 8 ml media. The cells were grown at 37°C in a humidified incubator 
which is kept constant at 5% CO2. 48 hours after starting a new cell line, the media was changed. 
When ~80% confluent, cells were counted with a hemocytometer and split. To store cell samples 
for future use, cells at ~80% confluency were washed with 5ml dPBS (ThermoFisher Scientific 
#14190136) and detached with 0.25% trypsin (ThermoFisher Scientific 25200072). Once 
detached, the cells were centrifuged for 2 minutes at 1000 rpm and the media was removed. Then 
the cells were resuspended in 1ml media + 10% DMSO, put in a styrofoam container and placed 
in -80° C.  
 
Expression of kmUTAG-fl and in vitro Assays 
A condon-optimized mCherry-kmUTAG ORF was generated as a bacterial 
overexpression clone. A double digest was performed to recover the mCherry-kmUTAG 
fragment, which is then inserted into the SPOT-tag plasmid pEV1 (chromotek.com). The 
resulting plasmid was transformed into BL21-STAR(DE3) cells (Muench et al., 2003). The cells 
were grown in SOC media containing 1% glycerol at 18°C for 20 hours until log-phase, 
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harvested with centrifugation, resuspended in 1x SUMO Protease Buffer (SPB) with 5mM TCEP 
and 1mM AEBSF (Peek et al., 2018) and sonicated at 10% duty cycle for 3 times, 20 sec each. 
kmUTAG-fl was precipitated with 20ul magnetic SPOT-trap beads. After quantification and 
analysis using SDS-PAGE gels, the proteins were stored in 20% glycerol and 5mM TCEP at -
80°C. 
To test the SUMO-trapping activity of the kmUTAG-fl, pulldown and binding reactions 
were performed. 2ug of kmUTAG-fl protein was added to dolphin-nose tubes containing 1x SPB 
with 5mM TCEP. For SUMO1 beads binding reaction, 20ul of SUMO1 beads was added to the 
tube and the reaction was nutated for 1hr at 4°C, spun down and washed three times with 1x SPB 
and eluted with 25ul of 2X SDS sample buffer. For SUMO-CAT pulldown reactions, 5ug of 
SUMO-CAT was added to the tube and incubated with the kmUTAG-fl protein for 1hr at 4°C. 
The mixture was transferred to 20ul SPOT-trap magnetic beads, and incubated with the beads for 
30 minutes at 4°C. SPOT-trap beads were eluted with 2X Reducing Sample Buffer (diluted from 
ThermoFisher #3900 Lane Marker Reducing Sample Buffer, which was 5X). 25µl of the reaction 
was run out on NUPAGE 4–12% Bis/Tris SDS PAGE gels. Gels were washed in water and then 
stained using Simply Blue G250 dye (Life technologies # LC6060) before scanning and 
quantitation using a BioRad imager and BioRad Image Lab software.  
 
SUMO-staining with kmUTAG-fl 
Cell were grown to 80% confluency and counted using a hemocytometer. Each well in 
the 6-well plate (Fisher Scientific 07-200-83) received 300,000 cells in 2 ml media. Cells were 
incubated for 24 hours until 80% confluent. After fixing the cells with 4% Paraformaldehyde (PF) 
for 20 minutes at room temperature in the laboratory safety hood, the cells were permeablized for 
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15 min with 0.1% Triton X-100 in dPBS. Next, the cells were treated with 0.1M Glycine-HCL 
(pH 2.0) for 10 seconds. The pH was immediately neutralized with 500ul of 10X SPB. After that 
the coverslips were removed from the well and placed into humidity chambers. For KmUTAG-fl 
only staining, 2ug of kmUTAG-fl was added to 100ul 1X SPB containing 5mM TCEP. The mix 
was transferred onto the coverslip and incubated at room temperature for 1hr in the humidity 
chamber. For KmUTAG-fl and anti-SUMO2/3 antibody co-staining, 2ug of kmUTAG-fl and 
0.5ul SUMO2/3 8A2 (obtained for Developmental Studies Hybridoma Bank (X.-D. Zhang et al., 
2008)) were mixed with 100ul blocking buffer, pipetted onto the coverslip, and incubated in 
room temperature for 1hr. After washing the coverslips with dPBS, 0.5ul anti-mouse Alexa Fluor 
488 conjugated antibody with 100ul Blocking buffer, and the mix was pipetted onto the coverslip 
of kmUTAG-fl and SUMO2/3 co-staining slides, incubate in room temperature for 1hr. After 
washes with dPBS, the coverslips were inverted onto precleaned microscopy slides with a drop 
of FLUORO-GEL II with DAPI. The slides were stored in -20°C freezer overnight before 
viewing under the microscope. 
 
Stress Treatment 
 To test the SUMO Stress Response (SSR) to UV damage, cells grown until ~80% 
confluent on coverslips were subjected to UV irradiation before proceeding with fixation and 
staining. The coverslips were first transferred from the 6-well plate to a humidity chamber. 
Excess media on the coverslip was removed yet the cells were kept moisturized in the humidity 
chamber. After removing the lid, the humidity chamber containing the coverslip was put into the 
UV chamber (GS Gene Linker UV Chamber). The UV ray intensity was adjusted per 
manufacturer’s protocol. After UV-irradiation, the coverslips were immediately put back into the 
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culture medium and incubated in cell culture incubator for 30 minutes. Afterwards, fixation and 
staining was proceeded with.  
 For peroxide stress treatment, H2O2 was added from 3M stock solution to 2 ml culture 
medium to a achieve desired final concentration. Cells grew to ~80% confluent were incubated 
with the mixture for 30 minutes in the tissue culture incubator. After incubation, the H2O2 
solution was removed and the cells were washed dPBS. Afterwards, fixation and staining was 
proceeded with.  
 
Microscopy and Data Analysis  
 Image was acquired using a fully automated Nikon A1R inverted confocal microscope 
using appropriate filter sets. For image analysis, background-subtracted images were quantified 
using two regions of interest (ROIs) in the cytoplasm and one ROI in nucleus of each cell. The 
ROIs’ mean fluorescence intensities were calculated using ImageJ or Nikon software. The 
relative nuclear enrichment was calculated as the ratio between mean nuclear and cytoplasmic 





kmUTAG-fl is a Fluorescent SUMO-Trapping Protein 
To provide a useful alternative to traditional antibody staining protocols, we developed a 
recombinant, mCherry tagged SUMO trapping protein, termed kmUTAG-fl. To produce the 
kmUTAG-fl, a codon-optimized mCherry-kmUTAG was cloned into pSpot1 plasmid (Figure 
1A), a Spot-Tag fusion protein expression vector for E. coli cells. After inducing gene expression 
with IPTG, the expressed kmUTAG-fl protein was purified on SPOT-Trap, an anti-Spot-Tag 
affinity resin. Recombinant kmUTAG-fl migrated at the expected molecular weight (~56.58 
kDa). The SUMO-trapping activity of the kmUTAG-fl was confirmed by precipitation with with 
SUMO1-conjugated bead (Figure 1B) and binding of a linear SUMO-CAT fusion protein (Figure 
1C). Briefly, purified SUMO-CAT protein was incubated with kmUTAG-fl and magnetic SPOT-
trap was used to pulldown kmUTAG-fl and associated SUMO-CAT protein (Figure 1C, lane 4). 
  The SUMO-trapping activity of kmUTAG-fl was also tested in mammalian cells. When 
observed using the appropriate filter set (Chroma) and a 100X oil-immersion objective on an 
Epifluorescent Zeiss Axioplan Microscope, kmUTAG-fl incubated with fixed, detergent-treated 
PNT2 cells exhibits a distinct nuclear localization pattern (Figure 1D- top right panel). Nuclear 
localization was confirmed using co-staining with DAPI (Figure 1D- top left panel). Both 
nuclear foci and diffuse nuclear staining were observed after staining of cells with kmUTAG-fl. 
This pattern resembles the SUMO-staining pattern observed using an anti-SUMO2/3 8A2 
antibody (Figure 1D- bottom left panel). Colocalization of anti-SUMO2/3 antibody signal with 
kmUTAG-fl (Figure 1D- bottom right panel) suggests that kmUTAG-fl detects SUMO2/3 in 




Enrichment of Cytosolic SUMO Levels and Increased Nuclear SUMO Foci in Cancer Cells upon 
UV-irradiation 
To understand what the differences of the SSR in normal and cancerous cells are, we 
investigated the impact of UV-induced DNA damage stress on two prostate cell types (non-
carcinogenic normal immortalized PNT2 cells and cancerous PC3 cells). PC3 and PNT2 cells 
were grown on coverslips and subjected to various doses of UV irradiation (30 mJ/m2, 50 mJ/m2, 
150 mJ/m2, 250 mJ/m2). After irradiation, the cells were allowed to recover for 30 minutes in 
culture medium, before fixing and staining with kmUTAG-fl. Increase in kmUTAG-fl staining 
after UV exposure (150 mJ/m2) was visually apparent in PC3 cells (Figure 2A left panel), but 
was less discernible in PNT2 cells (Figure 2A right panel). Levels of kmUTAG-fl were then 
measured and quantified using ImageJ, and revealed that while both PC3 and PNT2 displayed 
dosage-dependent increase in kmUTAG-fl staining in the nucleus, a significant increase of 
kmUTAG-fl signal was detected in the cytosol of PC3 cells when compared to PNT2 cells 
(Figure 2B). Comparing the un-irradiate control cells with cells that received 150 mJ/m2 of UV, 
we found that cytosolic kmUTAG-fl staining increased by 158.3% (1.5 fold) in PC3 cells (Figure 
2B left panel), whereas it increased by 38% (0.4 fold) in PNT2 cells (Figure 2B right panel). 
Concomitantly, the relative nuclear enrichment (RNE) of SUMO stain decreased more markedly 
in PC3 cells than in PNT2 cells (Figure 2C). Comparing the un-irradiate control cells with cells 
that received 150 mJ/m2 of UV, the RNE of PC3 cells decreased by 62.75% (Figure 2C left 
panel), whereas that of PNT2 cells decreased by 26% (Figure 2C right panel). 
Next to a more pronounced enrichment in cytosolic SUMO level, the cancerous cells 
respond to UV-irradiation with increased numbers of nuclear SUMO foci. From the control 
group to the 150 mJ/m2 UV-irradiated group, the nuclear SUMO foci increased by 40.3% in PC3 
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cells (Figure 1D left panel) and by 4% in the PNT2 cells. This may suggest that the SUMO 
conjugation in these foci increased as the UV dosage increased.  
 
Antibody Staining Revealed Similar UV-induced SSR Pattern in Cancer Cells 
  To confirm the increase of SUMO in our UV-irradiation experiments, we performed a co-
staining of UV irradiated cells with kmUTAG-fl and anti-SUMO2 8A2 antibody. After UV-
irradiation (250 mJ/m2) and recovery for 30 minutes, cells were fixed, stained and visualized as 
described above. A cytosolic increase in anti-SUMO2 antibody staining was detected when 
comparing mock-treated and irradiated cells (Figure 3). This colocalization confirms that 
kmUTAG-fl and SUMO antibody staining detect a similar re-distribution of SUMO due to 
genotoxic stress (Figure 3). Importantly, the merged image reveals that the kmUTAG-fl and 
SUMO2/3 nuclear foci colocalize with each other, albeit we note that the cytosolic kmUTAG-fl 
staining was more visible than the cytosolic antibody staining. Overall, the co-staining confirms 
that SUMO2/3 level increase in the cytosol of PC3 cells treated with UV-irradiation. 
 
Cancer Cells Subjected to Oxidative Stress Display an Enhanced SSR 
  We also wanted to investigate how the SSR unfolds when normal and carcinogenic 
prostate cells were subjected to oxidative stress. As before, PNT2 and PC3 cells grown on 
coverslips were treated with increasing concentrations of hydrogen peroxide (H2O2) for 30 
minutes before fixation and visualization of SUMO conjugates using the kmUTAG-fl reagent. 
The SUMO distribution was visualized and quantitated as detailed above. Similar to the UV-
irradiation treatment, an increase in kmUTAG-fl staining clearly detectable in PC3 cells as the 
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H2O2 concentration increased (Figure 4A left panel), and is less discernible in PNT2 cells 
(Figure 4A right panel).  
kmUTAG-fl staining revealed that H2O2 changes the global SUMO distribution in 
complex ways. First, we recorded a decrease of diffuse nuclear kmUTAG-fl staining in cells 
treated with 0.5uM and 25uM decreased (by 10.5% and 11.4% respectively) compared to control 
group in PC3 cells (Figure 4B). Concomitantly, when compared to a mock-treated control, the 
number of nuclear SUMO foci of PC3 cells increased by 26.3% [0.5 uM H2O2] and by 8.5% 
[25uM H2O2] (Figure 4D). At slightly higher H2O2 concentrations (1mM to 10mM), the diffuse 
SUMO staining in the nucleus of PC3 cells increased by 11.0% and 88.2% respectively (Figure 
4B). Meanwhile, the number of nuclear foci showed little of no change, with a slight decrease by 
4% and a slight increase by 0.8% from the control to the 1mM and 10mM H2O2 treated groups, 
respectively (Figure 4B). At high concentration of H2O2 (30mM), both diffuse kmUTAG-fl 
staining and the nuclear foci increased, by 93.9% and by 34.1% respectively compared to the 
control group (Figure 4B and 4D), suggesting that SUMO conjugation increased dramatically at 
high concentration of H2O2.  
 
Recovery from Oxidative Stress Exposure in both Cancer and Normal Cells is Accompanied by 
Restored SUMOylation Level 
  Previous evidence suggests that the SSR is involved in the stress resilience of cells, 
therefore we asked whether the SUMO redistribution would recover once the stressor is removed. 
Therefore, we conducted a recovery experiment using PC3 and PNT2. Cells grown on coverslips 
were treated with 1mM H2O2, washed, and recovered in culture media for 1, 2, 3, 4, and 5 hours 
post-H2O2-treatment. Cells were then fioxed and the visualization and quantification of SUMO 
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level and distribution was conducted as above. Again, a marked increase in kmUTAG-fl staining 
in the cytosol was observed in PC3 (Figure 5A, the second column to the left) and PNT2 cells 
treated with 1mM H2O2 (Figure 5B, the second column to the left). As the cells recovered from 
the peroxide stress, kmUTAG-fl staining intensity gradually diminished, from no recovery group 
to 5hr recovery group in both cell types (Figure 5). The quantification corroborated this visual 
observation, as the relative nuclear enrichment of SUMO signal first decreased by 78.9% in PC3 
cells and 30.9% in PNT2 cells, from control group to 1mM H2O2 treated no recovery group. 
Then, the RNE level in PC3 cells restored gradually as time progressed, from 78.9% decrease 
relative to control group, to 63.2%, 36.7%, 26.8%, 19.4% and 11.3% respectively after 1hr, 2hr, 
3hr, 4hr and 5hr, respectively (Figure 5C). Similarly, the RNE level in PNT2 cells restored 
gradually from 30.9% decrease relative to the control, to 19.2%, 6.3%, 16.51%, (-)12.36% and 
0.69% respectively after 1hr, 2hr, 3hr, 4hr and 5hr recovery (Figure 5C). However, no significant 






Figure 1: Schematic representation of the kmUTAG-fl protein and its SUMO-trapping activity. 
(A) Schematic representation of the kmUTAG-fl used in this study. The Spot-tag vector pSPOT1 is used for the 
expression of the kmUTAG-fl. (B) Binding of kmUTAG-fl to SUMO1 conjugated beads. kmUTAG-fl proteins were 
bound to the SUMO1 conjugated agarose beads in the presence of the reducing agent TCEP in 1x SUMO Protease 
Buffer (SPB: See Materials and methods). After three washes, proteins were eluted with 2x SDS-PAGE sample 
buffer and resolved on SDS-PAGE gels, and stained using a Coomassie G-250 stain (Lane 2). Lane 1 is the protein 
ladder with molecular weights indicated in kDa. (C) kmUTAG-fl precipitation of a SUMO-CAT fusion protein. 
Recombinant HIS6-SUMO-CAT protein was incubated with kmUTAG-fl in the presence of the reducing agent 
TCEP in 1x SPB. After incubation, SPOT-Trap beads were used to pull down the UTAG and the associated SUMO-
CAT. kmUTAG-fl and the associated proteins were eluted with Lane Marker Reducing Sample Buffer and 
visualized as detailed above. Lane 1 is the protein ladder with molecular weights indicated in kDa. Lane 2 to 4 are 
control groups. (D) kmUTAG-fl colocalization with SUMO2/3 in mammalian cells. PNT2 cells were grown on 
coverslips, fixed and co-stained with both kmUTAG-fl and anti-SUMO2 8A2 antibody, followed by mounting with 
media containing DAPI. The slide was visualized using a confocal microscope under appropriate filters for DAPI 
(DNA), mCherry (kmUTAG-fl), and GFP (anti-SUMO2/3). The confocal image reveals that kmUTAG-fl signal 




Figure 2: Cancer cells show an enhanced SSR to UV irradiation 
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Cells grown on coverslips were moved to humidity chambers, placed in the UV chamber and irradiated with 
different UV dosage (ranging from 0 (control) to 250 mJ/m2). Immediately thereafter, the coverslips were put back 
into media and recover for 30 minutes at 37°C with a constant 5% CO2 in tissue culture incubator. Then the cells 
were fixed and stained with kmUTAG-fl (See Methods), and visualized using a confocal microscope under 
appropriate filter sets for mCherry (kmUTAG-fl) and DAPI (red: kmUTAG-fl; blue: DAPI). The pictures were 
quantified using the ImageJ software. (A) Effects of different dosages of UV ray on the SUMO profile of PC3 and 
PNT2 cells. The dosage of UV used was noted below the images. All the scale bars = 20 µm. (B) The diffuse 
kmUTAG-fl signal intensity in PC3 and PNT2 cells across treatment groups. Background-subtracted images were 
quantified using two regions of interest (ROIs) in the cytoplasm and one ROI in the nucleus of each cell. The ROI’s 
mean fluorescence intensities were calculated as diffuse staining intensity using the software ImageJ. 20 cells were 
analyzed per treatment group. Error bars denoted the mean ± SD of each group. (C) The relative nuclear enrichment 
(RNE) ratio of the kmUTAG-fl signal in PC3 cells (left panel) and PNT2 cells (right panel) irradiated with different 
dosages of UV. The relative nuclear enrichment was calculated as the ratio between nuclear and mean cytoplasmic 
fluorescence intensities. All RNEs were plotted on the graph as dots. Data labels were added to the average RNE of 
each group. Error bars were displayed in green denoting the mean ± SD of each group. (D) Nuclear foci counting of 
PC3 and PNT2 cells relative to the dosage of UV. The nuclear foci were counted using “Find Maxima” function in 





Figure 3: Anti-SUMO2 8A2 antibody co-staining of UV irradiated cancerous cells 
PC3 cells grown on coverslips were moved to a humidity chamber, placed in the UV chamber and irradiated with 
250 mJ/m2 UV ray. After a 30-minute recovery at 37°C with a constant 5% CO2 in tissue culture incubator, the cells 
were fixed and co-stained with kmUTAG-fl and anti-SUMO2 8A2 antibody (See Methods), and visualized using a 
confocal microscope using appropriate filters. Cells in the upper row were not UV-irradiated, whereas the cells in 
the lower row was irradiated by 250mJ/m2 UV ray. In the “merge” images, red = kmUTAG-fl, green = anti-SUMO2 




Figure 4: Cancer cells show an enhanced SSR to H2O2 stress 
Cells were grown coverslips and treated H2O2 of different concentration in culture for 30 minutes at 37°C with a 
constant 5% CO2 in tissue culture incubator. No H2O2 was added to the cells in the control group. After a brief wash 
with DPBS, the cells were fixed and stained with kmUTAG-fl, visualized and quantified as previously described. (A) 
Effects of different concentrations of H2O2 on the SUMOylation level in PC3 cells and PNT2 cells. PC3 cells treated 
with H2O2 show a concentration-dependent increase in SUMO staining in the nucleus and the cytosol. The 
concentration of H2O2 used was noted below the images. All the scale bars = 20 µm. (B) The diffuse kmUTAG-fl 
signal intensity in PC3 and PNT2 cells across treatment groups. Error bars denoted the mean ± SD of each group. (D) 
The relative nuclear enrichment (RNE) ratio of the kmUTAG-fl signal in PC3 cells (left panel) and PNT2 cells 
(right panel) treated with different concentrations of H2O2. 20 cells were analyzed per treatment group. Note that 
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only 10 cells were analyzed in 30mM H2O2 treated PC3 cells group, due to the loss of cells during treatment. All 
RNEs were plotted on the graph as dots. Data labels were added to the average RNE of each group. Error bars were 
displayed in green denoting the mean ± SD of each group. (D) Nuclear foci counting of PC3 and PNT2 cells relative 
to the concentration of H2O2 used. The nuclear foci were counted using “Find Maxima” function in ImageJ. Noise 







Figure 5: Recovery from peroxide stress is accompanied by gradually-restored SUMO level 
Cells were grown coverslips and treated with 1mM H2O2 for 30 minutes at 37°C with a constant 5% CO2 in tissue 
culture incubator. After washing with DPBS, the cells were supplemented with fresh media, placed in the incubator 
to allow for recovery. The cells were then fixed after being recovered for 1-5 hours respectively, and stained with 
kmUTAG-fl, visualized and quantified as previously described. All the scale bars = 20 µm. The SUMOylation level 
of PC3 cells (A) and PNT2 cells (B) treated with H2O2 gradually recovered to the control level over time. (C) The 
relative nuclear enrichment (RNE) ratio of the kmUTAG-fl signal in PC3 cells (left panel) and PNT2 cells (right 
panel) treated with different concentrations of H2O2. 20 cells were analyzed per treatment group. All RNEs were 
plotted on the graph as dots. Data labels were added to the average RNE of each group. Error bars were displayed in 
green denoting the mean ± SD of each group. (D) Nuclear foci counting of PC3 and PNT2 cells relative to the length 








In this work, we used kmUTAG-fl, a novel fluorescent SUMO trapping UTAG reagent, 
to visualize and study the SSR in cancerous and normal cells. Specifically, we analyzed the 
localization of SUMO conjugates in stressed vs. unstressed and normal vs. cancerous cells. In 
doing so, we found that the SUMO levels and distribution are grossly altered after exposure to 
proteotoxic stress, with an enhanced increase in carcinogenic cells. Additionally, such alteration 
is not limited to the nucleus, as we observe a drastic increase in cytosolic SUMO staining in 
cancer cells subjected to stress treatments. To our knowledge this is the first observation of a 
dramatic and rapid increase in cytosolic SUMO levels in cancerous cells under stress conditions, 
which was previously uncharacterized. 
 
kmUTAG-fl Visualizes SUMO Level Modulations 
  We first determined that kmUTAG-fl detects SUMO level alterations in stressed cells 
(Figure 2A and Figure 3A). Specifically we found that kmUTAG-fl signal show a UV-dosage 
dependent increase and a H2O2-concentration dependent increase in the nucleus and the cytosols 
of cancer cells. Indeed, the kmUTAG-fl signal is reminiscent of SUMO signal, as our data 
reveals that kmUTAG-fl staining colocalizes with SUMO2/3 foci in mammalian nuclei and 
compares favorably to SUMO antibody-staining (Figure 1B). However, the specific protein (or 
proteins) that are increased after stress remain to be identified. One possibility is that KmUTAG-
fl traps and binds SUMO-modified proteins that are newly sumoylated in response to stress. 
Another possibility is that an increase of sumoylated proteins in the cytosol is due to release of a 
sumoylated protein from the nucleus. 
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Apart from binding to SUMO2/3, kmUTAG-fl binds other isoforms of SUMO including 
SUMO1 (Figure 1B, SUMO1 bead precipitation of kmUTAG-fl) and SUMO variants in other 
eukaryotic cells. This pan-SUMO binding activity is most likely due to the conserved tertiary 
structure of all SUMO isoforms. Unlike SUMO antibodies kmUTAG-fl recognizes the tertiary 
structure of SUMO, instead of an epitope. The pan-SUMO binding activity of kmUTAG-fl is 
borne out in data from our recent publication, where kmUTAG-fl labels nematode SUMO-
modified proteins in gonads from oocyte-producing adult hermaphrodites. Again, the kmUTAG-
fl staining pattern corroborates a previously reported anti-SUMO antibody localization pattern 
[Yin et al., 2019]. 
 
Alterations of SUMO Homeostasis in Cancer Cells. 
  We have observed increased levels of kmUTAG-fl staining in stressed cancer cells (PC3). 
For instance, figure 2A (left panel) and 2B (left panel) reveal that kmUTAG-fl signal is enriched 
in the cytosol and nucleus of prostate cancer cells that were subjected to UV irradiation. 
Similarly, kmUTAG-fl signal was enriched in the nucleus and the cytosol of prostate cancer cells 
treated with high concentrations of H2O2 (1mM, 10mM 30mM). Given that kmUTAG-fl stains 
SUMO-modified proteins, we conclude that SUMO conjugate levels are enhanced in cancer cells 
subjected to stress treatment. 
  In the nuclei of cancer cells, an increase in diffuse-staining SUMO was detected with the 
onset of stress [Figure 2 B left panel, Figure 4B left panel], additionally a 40.3% increase in 
nuclear SUMO foci count was observed UV-irradiated cells (150mJ/m2) [Figure 2D left panel]. 
This suggests that UV-induced damage increased SUMO conjugation in specific domains of the 
nucleus of cancer cells. This is consistent previous findings, because SUMO is important for 
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repairing the DNA damage caused by the UV irradiation. UV irradiation leads to the formation 
of thymine dimers which require DNA repair enzymes to resolve the resulting DNA lesions 
[Masuma et al., 2016]. Several proteins are recruited to sites of DNA damage because of 
SUMOylated Mdc1 [Yin et al., 2012]. Mdc1, a DNA damage checkpoint mediator protein that 
forms foci at dsDNA break sites and is then SUMOylated by PIAS1/4 [reviewed in Kerscher 
2016]. Additionally, kmUTAG-fl kmUTAG-fl co-localized with PML, a protein which forms 
nuclear bodies with critical role in DNA damage repair. We were able to show that anti-PML 
antibodies colocalize to the kmUTAG-fl signal in PNT2 cells. It has previously been published 
that PML becomes upregulated and PML bodies are increased in numbers [Varadaraj et al., 
2007]. 
 
Figure 6. kmUTAG-fl colocalization with PML in mammalian cells. PNT2 cells were grown on coverslips, fixed 
and co-stained with both kmUTAG-fl and anti-PML antibody, followed by mounting with media containing DAPI. 
The slide was visualized using a confocal microscope under appropriate filters for DAPI (DNA), mCherry 
(kmUTAG-fl), and GFP (anti-PML). The confocal image reveals that kmUTAG-fl signal colocalizes with the anti-
PML signal. the Scale bar = 20 µm. 
  
Apart from an increase in SUMO stain in the nucleus, we detected an increase in 
cytosolic SUMO staining in cancerous cells subjected to stress (what kind) treatments [left 
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panels of figure 2A, 2B, 4A, 4B]. Though researchers have previously identified cytosolic 
SUMO targets, there is no prior evidence that stress induces increased SUMO levels in the 
cytosol. We hypothesize that this increase in SUMO facilitates the stress resilience of cancer 
cells, for SUMO modification increases the solubility of misfolded proteins when cells are 
stressed. This stress induced SUMOylation could prevents proteins from aggregating and thus 
maintain protein homeostasis. Once the stressor is removed, this effect could be reversed by 
SUMO proteases to restore regular protein function (Figure 5A, 5B). Indeed, we observed that 
cytosolic kmUTAG-fl levels rapidly returned to normal when cells recovered after stress (Figure 
5A). 
 
Future Goals for kmUTAG-fl 
  Forward-looking, we aim to address two major question using the KmUTAG-fl reagent. 
First, we aim to link the increase of SUMO levels to the enhanced oncogenic potential of 
cancerous cells. The oncogenic potential is defined as an increase in cellular migration, 
invasiveness, and aggressive cell proliferation. We will test this in collaboration with the 
laboratory of Dr. Esquela-Kerscher at the nearby Leroy T. Canoles Jr. Cancer Research Center, 
EVMS, Norfolk. We will stain SUMO with kmUTAG-fl in additional prostate cancer cell lines 
transformed with small noncoding microRNAs (e.g. miR-888, miR-891a) that promotes the 
tumorigenicity of prostate cancer cells, as well as microRNAs that suppresses tumorigenicity 
(e.g., let-7c, miR-200c) [Lewis et al., 2014]. Our preliminary data suggest that SUMO level was 
elevated in cancerous cells transformed with microRNAs that enhance tumorigenicity (data not 
shown). It is generally accepted that cells with enhanced tumorigenicity show increased levels of 
DNA alterations as well as grossly disrupted protein homeostasis that may make them dependent 
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on the chaperone-like function of SUMO for protein maintenace. Establishing a link between 
SUMO levels and oncogenic potential will underscore the importance that the SSR plays during 
cellular transformation. 
  Second, to further understand how SSR unfolds in cancer cells, we plan to use a cell-
penetrating CPP-adaptor system to deliver and release the kmUTAG-fl into the cytoplasm of 
mammalian cells [Salerno et al., 2016]. Several cargo proteins, like myoglobin, horseradish 
peroxidase, and ß-galactosidase have been intracellularly delivered, using this system, to various 
cell lines (e.g. HEK and HT-3). In collaboration with Dr. McMurry from Kennesaw University, 
we plan to fuse kmUTAG-fl to a calmodulin binding site, which will be carried by calmodulin-
fused cell penetrating peptide (CPP). The successful delivery of kmUTAG-fl will allow us to 
visualize the propagation of SSR inside living cells and study the SUMO-specific features as 
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